ARC Advisory Group today announced the publication of its new ARC MarketMap for Manufacturing Execution Systems (MES) in Pharmaceutical & Biotech Industries, an independent research study evaluating leading suppliers serving the life sciences manufacturing market. The report provides a structured assessment of supplier capabilities, strategic direction, and competitive positioning at a time when pharmaceutical and biotech manufacturers are accelerating digital transformation initiatives and modernizing production operations.
Manufacturing Execution Systems have become a critical component of pharmaceutical and biotech manufacturing strategies, serving as the operational layer connecting enterprise applications, automation systems, quality processes, and production execution. As manufacturers seek greater visibility, agility, and compliance, MES platforms continue to evolve from traditional production management tools into comprehensive manufacturing operations management solutions that support end-to-end digital manufacturing initiatives.
Manufacturing Execution Systems for Pharmaceutical & Biotech Market Trends
Several market trends are reshaping MES requirements across the pharmaceutical and biotechnology industries. Organizations are increasingly adopting unified data architectures, cloud-enabled deployment models, electronic batch records, advanced analytics, and artificial intelligence to support more intelligent and connected manufacturing operations. At the same time, manufacturers must adapt to increasingly complex production environments driven by biologics, cell and gene therapies, personalized medicines, and evolving regulatory expectations, including risk-based validation approaches and Computer Software Assurance (CSA) methodologies.
These changes have increased the complexity of supplier selection and technology investment decisions. Buyers must evaluate not only traditional MES functionality, but also factors such as integration capabilities, scalability, deployment flexibility, regulatory compliance support, analytics capabilities, cloud readiness, and long-term innovation strategies. As a result, many organizations are looking for independent market intelligence that can help them align MES investment decisions with broader operational and business transformation objectives.
A Structured Assessment of Capabilities and Direction
The ARC MarketMap delivers an independent, analyst-led evaluation of the MES supplier landscape using ARC’s established research methodology. Suppliers are assessed across two primary dimensions: Solution Capabilities and Strategic Vision. The evaluation framework examines technical capabilities, functional capabilities, execution and support services, product vision and strategy, corporate strategy, and customer base. The analysis incorporates supplier briefings, demonstrations, secondary research, supplier questionnaires, and ARC’s industry expertise to provide practical decision-support guidance for technology buyers and market participants.
Suppliers evaluated in this MarketMap include: ABB, Apprentice.io, Aptean, Aspen Technology, AVEVA, Constellation Software, Dassault Systemes, Durr, Elisa Industriq, Emerson Automation Solutions, Epicor, Honeywell, Körber, MasterControl, MPDV, Parsec Automation Corp, Rockwell Automation, Samsung, SAP, Sepasoft, Siemens, Tulip, and Vimachem.
Beyond supplier positioning, the report includes detailed supplier profiles, market analysis, industry trends, supplier landscape assessments, concentration matrix analysis, and practical buyer recommendations designed to help organizations evaluate and shortlist MES providers based on their specific manufacturing requirements and digital transformation priorities.
Analyst Perspective
“Manufacturing execution systems have evolved into foundational platforms for pharmaceutical and biotech digital transformation, connecting manufacturing operations, quality processes, and enterprise systems while supporting greater visibility, compliance, and operational agility,” said Janice Abel, Senior Analyst, ARC Advisory Group. “As organizations modernize production environments and pursue Pharma 4.0 initiatives, understanding supplier capabilities and long-term strategic direction becomes increasingly important to successful technology selection and deployment.”
About ARC MarketMap
ARC MarketMap reports provide independent, research-driven assessments of technology suppliers within defined industrial and enterprise software markets. Using a structured evaluation methodology, MarketMaps help technology buyers assess supplier strengths, strategic direction, solution capabilities, and market positioning. The framework is designed to support informed technology decisions while providing suppliers with competitive market insights and benchmarking perspectives.
Learn More
Learn more about the ARC MarketMap for Manufacturing Execution Systems in Pharmaceutical & Biotech Industries and see a sample report.